| Taspoglutide, an analog of human glucagon-like Peptide-1 with enhanced stability and in vivo potency. | |
| | |
MedLine Citation:
|
PMID: 20382695 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Taspoglutide is a novel analog of human glucagon-like peptide-1 [hGLP-1(7-36)NH2] in clinical development for the treatment of type 2 diabetes. Taspoglutide contains alpha-aminoisobutyric acid substitutions replacing Ala(8) and Gly(35) of hGLP-1(7-36)NH2. The binding affinity [radioligand binding assay using [(125)I]hGLP-1(7-36)NH2], potency (cAMP production in CHO cells stably overexpressing hGLP-1 receptor), and in vitro plasma stability of taspoglutide compared with hGLP-1(7-36)NH2 have been evaluated. Effects on basal and glucose-stimulated insulin secretion were determined in vitro in INS-1E cells and in vivo in normal rats. Taspoglutide has comparable affinity (affinity constant 1.1 +/- 0.2 nm) to the natural ligand (affinity constant 1.5 +/- 0.3 nm) for the hGLP-1 receptor and exhibits comparable potency in stimulating cAMP production (EC(50) Taspo 0.06 nm and EC(50) hGLP-1(7-36)NH2 0.08 nm). Taspoglutide exerts insulinotropic action in vitro and in vivo and retains the glucoincretin property of hGLP-1(7-36)NH2. Stimulation of insulin secretion is concentration dependent and evident in the presence of high-glucose concentrations (16.7 mm) with a taspoglutide concentration as low as 0.001 nm. Taspoglutide is fully resistant to dipeptidyl peptidase-4 cleavage (during 1 h incubation at room temperature with purified enzyme) and has an extended in vitro plasma half-life relative to hGLP-1(7-36)NH2 (9.8 h vs. 50 min). In vitro, taspoglutide does not inhibit dipeptidyl peptidase-4 activity. This study provides the biochemical and pharmacological basis for the sustained plasma drug levels and prolonged therapeutic activity seen in early clinical trials of taspoglutide. Excellent stability and potency with substantial glucoincretin effects position taspoglutide as a promising new agent for treatment of type 2 diabetes. |
| | |
Authors:
|
Elena Sebokova; Andreas D Christ; Haiyan Wang; Sabine Sewing; Jesse Z Dong; John Taylor; Michael A Cawthorne; Michael D Culler |
Related Documents
:
|
6526265 - Use of the artificial beta cell (abc) in the assessment of peripheral insulin sensitivi... 2687145 - Postreceptor regulation of insulin action in primary cultures of rat hepatocytes by ora... 701385 - Responsiveness to insulin is a dominant characteristic in somatic cell hybrids. 18287215 - Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 ... 11128745 - Maternal and fetal serum lipid and lipoprotein concentrations and compositions in type ... 3830845 - Survey of foot deformities among 166 geriatric inpatients. |
Publication Detail:
|
Type: Journal Article Date: 2010-04-09 |
Journal Detail:
|
Title: Endocrinology Volume: 151 ISSN: 1945-7170 ISO Abbreviation: Endocrinology Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-05-21 Completed Date: 2010-06-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375040 Medline TA: Endocrinology Country: United States |
Other Details:
|
Languages: eng Pagination: 2474-82 Citation Subset: AIM; IM |
Affiliation:
|
F. Hoffmann-La Roche AG, PRDM, Building 68/310 Grenzacherstrasse 124, CH-4070 Basel, Switzerland. elena.sebokova@roche.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antigens, CD26 / metabolism CHO Cells Cell Line, Tumor Cricetinae Cricetulus Cyclic AMP / metabolism Drug Stability Enzyme-Linked Immunosorbent Assay Glucagon-Like Peptide 1 / analogs & derivatives* Humans Insulin / metabolism Peptides / blood, chemistry, pharmacokinetics, pharmacology* Protein Binding Rats Rats, Sprague-Dawley Receptors, Glucagon / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Peptides; 0/Receptors, Glucagon; 0/glucagon-like peptide receptor; 0/taspoglutide; 11061-68-0/Insulin; 60-92-4/Cyclic AMP; 89750-14-1/Glucagon-Like Peptide 1; EC 3.4.14.5/Antigens, CD26; EC 3.4.14.5/DPP4 protein, human |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Adipocyte-Derived Microvesicles Are Associated with Multiple Angiogenic Factors and Induce Angiogene...
Next Document: Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heighte...